Juliette Svahn

571 total citations
18 papers, 155 citations indexed

About

Juliette Svahn is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Juliette Svahn has authored 18 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Juliette Svahn's work include Peripheral Neuropathies and Disorders (7 papers), Myasthenia Gravis and Thymoma (5 papers) and Hereditary Neurological Disorders (4 papers). Juliette Svahn is often cited by papers focused on Peripheral Neuropathies and Disorders (7 papers), Myasthenia Gravis and Thymoma (5 papers) and Hereditary Neurological Disorders (4 papers). Juliette Svahn collaborates with scholars based in France, Switzerland and Martinique. Juliette Svahn's co-authors include Jean‐Philippe Camdessanché, Christophe Vial, Karine Viala, Jean‐Christophe Antoine, Antoine Pégat, Karine Férraud, Laurent Magy, Françoise Bouhour, Jean‐Marc Léger and Philippe Petiot and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neurology Neurosurgery & Psychiatry and Lara D. Veeken.

In The Last Decade

Juliette Svahn

14 papers receiving 153 citations

Peers

Juliette Svahn
Ryan Keh United Kingdom
Jean Neil France
John‐Philip Lawo United States
Mohammad Alsharabati United States
Alistair Church United Kingdom
Juliette Svahn
Citations per year, relative to Juliette Svahn Juliette Svahn (= 1×) peers Maria Alberti

Countries citing papers authored by Juliette Svahn

Since Specialization
Citations

This map shows the geographic impact of Juliette Svahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliette Svahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliette Svahn more than expected).

Fields of papers citing papers by Juliette Svahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliette Svahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliette Svahn. The network helps show where Juliette Svahn may publish in the future.

Co-authorship network of co-authors of Juliette Svahn

This figure shows the co-authorship network connecting the top 25 collaborators of Juliette Svahn. A scholar is included among the top collaborators of Juliette Svahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliette Svahn. Juliette Svahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Delorme, Cécile, Antoine Pégat, Jean‐Philippe Brandel, et al.. (2025). Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt–Jakob disease in two patients. Annals of Clinical and Translational Neurology. 12(3). 653–658.
2.
Péréon, Yann, David Adams, Jean‐Philippe Camdessanché, et al.. (2025). Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study. Orphanet Journal of Rare Diseases. 20(1). 95–95. 1 indexed citations
3.
Pégat, Antoine, Juliette Svahn, Ludivine Kouton, et al.. (2025). Is the decrement pattern in myasthenia gravis due to muscle-specific kinase antibodies different to that due to acetylcholine receptor antibodies?. Neurophysiologie Clinique. 55(6). 103092–103092.
4.
Hermier, M., Geneviève Demarquay, Véronique Rogemond, et al.. (2023). Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease. Neurology Neuroimmunology & Neuroinflammation. 10(6). 5 indexed citations
5.
Robert, Marie, Françoise Bouhour, Philippe Petiot, et al.. (2023). Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study. Lara D. Veeken. 63(2). 506–515. 2 indexed citations
6.
Fernández‐Eulate, Gorka, Philippe Latour, Tanya Stojkovic, et al.. (2023). Genetic characterization of non-5q proximal spinal muscular atrophy in a French cohort: the place of whole exome sequencing. European Journal of Human Genetics. 32(1). 37–43. 2 indexed citations
7.
Pégat, Antoine, Émilien Delmont, Juliette Svahn, et al.. (2022). Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies. Neurology Neuroimmunology & Neuroinflammation. 9(3).
8.
Benoit, Charline, Juliette Svahn, Rabab Debs, et al.. (2021). Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features. Journal of the Peripheral Nervous System. 26(2). 193–201. 7 indexed citations
9.
Bernard, E, Antoine Pégat, Juliette Svahn, et al.. (2020). Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study. International Journal of Molecular Sciences. 21(18). 6807–6807. 30 indexed citations
10.
Svahn, Juliette, et al.. (2020). Miastenia e sindromi miasteniche. 20(3). 1–26. 1 indexed citations
11.
Svahn, Juliette, Pascal Laforêt, Christophe Vial, et al.. (2019). Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene. Neuromuscular Disorders. 29(7). 497–502. 7 indexed citations
12.
Moritz, Christian P., et al.. (2019). Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique. PROTEOMICS - CLINICAL APPLICATIONS. 13(4). e1800157–e1800157. 9 indexed citations
13.
Svahn, Juliette, P. Petiot, J. C. Antoine, et al.. (2018). Anti-MAG antibodies in 202 patients: Clinicopathological and therapeutic features. Revue Neurologique. 174. S165–S165. 2 indexed citations
14.
Svahn, Juliette, Philippe Petiot, Jean‐Christophe Antoine, et al.. (2017). Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. Journal of Neurology Neurosurgery & Psychiatry. 89(5). 499–505. 68 indexed citations
15.
Svahn, Juliette, Nathalie Streichenberger, Olivier Benvéniste, et al.. (2015). Significant response to immune therapies in a case of subacute necrotizing myopathy and FKRP mutations. Neuromuscular Disorders. 25(11). 865–868. 4 indexed citations
16.
Svahn, Juliette, J.‐C. Antoine, & Jean‐Philippe Camdessanché. (2014). Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies. Revue Neurologique. 170(12). 808–817. 13 indexed citations
17.
Svahn, Juliette, Tae‐Hee Cho, Laurent Derex, Laura Mechtouff, & Norbert Nighoghossian. (2013). Hémorragie sous-arachnoïdienne et anomalies vasculaires cérébrales multiples au cours d’une β-thalassémie majeure. Revue Neurologique. 169(3). 266–268. 4 indexed citations
18.
Svahn, Juliette, N. Vandenberghe, Hélène Gervais‐Bernard, et al.. (2013). Diagnostics de sclérose latérale amyotrophique (SLA) par excès : expérience du centre SLA de Lyon à propos de 18 patients. Revue Neurologique. 169. A60–A60.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026